AbbVie (ABBV) Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain

Source Link:

https://news.abbvie.com/news/abbvie-submits-new-drug-application-to-us-fda-for-investigational-oral-treatment-elagolix-for-management-endometriosis-with-associated-pain.htm